Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis

被引:130
作者
Yin, ZH
Braun, J
Neure, L
Wu, PH
Liu, LZ
Eggens, U
Sieper, J
机构
[1] FREE UNIV BERLIN,KLINIKUM BENJAMIN FRANKLIN,DEPT MED,DIV NEPHROL & RHEUMATOL,D-12200 BERLIN,GERMANY
[2] DEUTSCH RHEUMA FORSCHUNGSZENTRUM,BERLIN,GERMANY
来源
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 10期
关键词
D O I
10.1002/art.1780401010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective, To investigate whether a predominant type 1 T helper (Th1) or Th2 cytokine pattern is present in the joints of patients with reactive arthritis (ReA), and whether the cytokine pattern can be modulated by cytokines or anticytokines. Methods. Eleven patients with ReA following infection with either Chlamydia trachomatis, Yersinia enterocolitica, or Salmonella enteritidis were investigated for the presence of Th1/Th2 cytokines in the joints, Release of the bacteria-specific cytokines interferon-gamma (IFN gamma), tumor necrosis factor alpha (TNF alpha), interleukin-10 (IL-10), and IL-4 was measured in synovial fluid mononuclear cells (SFMC) using enzyme-linked immunosorbent assay and polymerase chain reaction, In the synovial membrane, secretion of IFN gamma and IL-4 was determined by immunohistologic analysis, Cytokine regulation was studied by adding cytokines and anticytokines to the cultures, Results. Upon stimulation with specific bacteria, SFMC secreted low amounts of IFN gamma and TNF alpha, but high amounts of IL-10, IL-10 was responsible for the suppression of IFN gamma and TNF alpha, as judged by the effect of adding either anti-IL-10 antibodies or exogenous IL-10 to these cultures, The addition of neutralizing anti-IL-12 to the cultures completely abolished the effects of anti-IL-10, suggesting that inhibition of the Th1-like cytokines by IL-10 is mediated through suppression of IL-12 synthesis, Exogenous IL-12 clearly enhanced IFN gamma and TNF alpha secretion, In the synovial membrane, a higher number of cells were positive for the Th2 cytokine IL-4, compared with the amount of IFN gamma-secreting cells. Conclusion. These data indicate that a Th2 cytokine pattern predominates in the joints of patients with ReA. Since Th1 cytokines are necessary for the elimination of ReA-associated bacteria, Th2 cytokines might contribute to bacterial persistence in the joint, Therefore, the IL-10/IL-12 balance appears to be crucial for regulation of the cytokine pattern in the joints of patients with ReA.
引用
收藏
页码:1788 / 1797
页数:10
相关论文
共 53 条
[1]   IMMUNE-RESPONSES TO YERSINIA-ENTEROCOLITICA IN SUSCEPTIBLE BALB/C AND RESISTANT C57BL/6 MICE - AN ESSENTIAL ROLE FOR GAMMA-INTERFERON [J].
AUTENRIETH, IB ;
BEER, M ;
BOHN, E ;
KAUFMANN, SHE ;
HEESEMANN, J .
INFECTION AND IMMUNITY, 1994, 62 (06) :2590-2599
[2]  
AUTENRIETH IB, 1992, MED MICROBIOL IMMUN, V181, P333
[3]   AMPLIFICATION OF PLASMID AND CHROMOSOME CHLAMYDIA DNA IN SYNOVIAL-FLUID OF PATIENTS WITH REACTIVE ARTHRITIS AND UNDIFFERENTIATED SERONEGATIVE OLIGOARTHROPATHIES [J].
BAS, S ;
GRIFFAIS, R ;
KVIEN, TK ;
GLENNAS, A ;
MELBY, K ;
VISCHER, TL .
ARTHRITIS AND RHEUMATISM, 1995, 38 (07) :1005-1013
[4]   MORPHOLOGIC AND ANTIGENIC CHARACTERIZATION OF INTERFERON GAMMA-MEDIATED PERSISTENT CHLAMYDIA-TRACHOMATIS INFECTION INVITRO [J].
BEATTY, WL ;
BYRNE, GI ;
MORRISON, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :3998-4002
[5]  
Bessis Natacha, 1995, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V189, P579
[6]  
Bohn E, 1996, J IMMUNOL, V156, P1458
[7]  
BRAUN J, 1993, Z RHEUMATOL, V52, P201
[8]   USE OF IMMUNOHISTOLOGIC AND IN-SITU HYBRIDIZATION TECHNIQUES IN THE EXAMINATION OF SACROILIAC JOINT BIOPSY SPECIMENS FROM PATIENTS WITH ANKYLOSING-SPONDYLITIS [J].
BRAUN, J ;
BOLLOW, M ;
NEURE, L ;
SEIPELT, E ;
SEYREKBASAN, F ;
HERBST, H ;
EGGENS, U ;
DISTLER, A ;
SIEPER, J .
ARTHRITIS AND RHEUMATISM, 1995, 38 (04) :499-505
[9]  
BRAUN J, 1997, J RHEUMATOL, V24, P102
[10]   Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein [J].
Brocke, S ;
Gijbels, K ;
Allegretta, M ;
Ferber, I ;
Piercy, C ;
Blankenstein, T ;
Martin, R ;
Utz, U ;
Karin, N ;
Mitchell, D ;
Veromaa, T ;
Waisman, A ;
Gaur, A ;
Conlon, P ;
Ling, N ;
Fairchild, PJ ;
Wraith, DC ;
OGarra, A ;
Fathman, CG ;
Steinman, L .
NATURE, 1996, 379 (6563) :343-346